Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations. Narasimhalu Kaavya et al. Clinical drug investigation 2020 Sep

Hot Topics of the Day|PHGKB




Last Posted: Oct 01, 2020

---

• Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations.
  Narasimhalu Kaavya et al. Clinical drug investigation 2020 Sep
• Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors.
  Banerjee Sudeep et al. JAMA network open 2020 Sep 3(9) e2013565
• Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients.
  Schluckebier Luciene et al. BMC cancer 2020 Sep 20(1) 875
• Cost-effectiveness analysis of using the TBX6-associated congenital scoliosis risk score (TACScore) in genetic diagnosis of congenital scoliosis.
  Chen Zefu et al. Orphanet journal of rare diseases 2020 Sep 15(1) 250
• Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
  Kapoor Ritika et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2020 Sep 23(9) 1171-1179
• Literature Review Concerning the Challenges of Implementing Pharmacogenetics in Primary Care Practice.
  Omer Mohamed S et al. Cureus 2020 Aug 12(8) e9616
• First trimester anomaly scan using virtual reality (VR FETUS study): study protocol for a randomized clinical trial.
  Pietersma C S et al. BMC pregnancy and childbirth 2020 Sep 20(1) 515
• Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencing.
  Almomani Rowida et al. PloS one 2020 15(9) e0238467
• Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values.
  Costa Sarah et al. The patient 2020 Sep
• Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.
  B Tata Emiliene et al. Pharmaceutics 2020 Aug 12(9)

more